DT-PR2215

N/A

Report date: 2024/10/29 14:19:10

Base Information

Drug NameDT-PR2215
Drug Alias NameDT-PR2215DT-PR-2215
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSchizophrenia, Childhood
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesYuan Da Medicine (Xi'an) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesYuan Da Medicine (Xi'an) Co Ltd
Inactive CompaniesN/A
Active IndicationsSchizophrenia, Childhood
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A